RetinalGenix Technologies (RTGN) Other Accumulated Expenses (2021 - 2026)
RetinalGenix Technologies (RTGN) reported Other Accumulated Expenses of $468428.0 for Q1 2026, up 164.65% on a YoY basis from $177002.0 in Q1 2025, and down 30.59% sequentially from $674842.0 in Q4 2025.
RetinalGenix Technologies (RTGN) Other Accumulated Expenses (2021 - 2026) Analysis & Trends
RetinalGenix Technologies (RTGN) has 6 years of Other Accumulated Expenses data on file, last reported at $468428.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Accumulated Expenses rose 164.65% year-over-year to $468428.0; the trailing twelve-month figure through Mar 2026 stood at $468428.0 (up 164.65% YoY), and the FY2025 full-year result was $674842.0, up 4195.89% from the prior year.
- Other Accumulated Expenses declined to $468428.0 in Q1 2026, from $674842.0 in the prior quarter.
- In the past five years, Other Accumulated Expenses ranged from a high of $811176.0 in Q2 2023 to a low of $901.0 in Q3 2023.
- A 5-year average of $385842.3 and a median of $430309.0 in 2024 frame the typical range for Other Accumulated Expenses.
- Across the five-year window, Other Accumulated Expenses sank 99.84% in 2023 and soared 56427.08% in 2024, its largest moves.
- Tracing RTGN's Other Accumulated Expenses over 5 years: stood at $427933.0 in 2022, then tumbled by 99.36% to $2760.0 in 2023, then surged by 469.17% to $15709.0 in 2024, then soared by 4195.89% to $674842.0 in 2025, then sank by 30.59% to $468428.0 in 2026.
- Business Quant data shows RTGN's Other Accumulated Expenses at $468428.0 in Q1 2026, $674842.0 in Q4 2025, and $539052.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | RetinalGenix Technologies | 75.02 Mn | 75.02 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 468,428.00 |
| Dec 31, 2025 | 674,842.00 |
| Sep 30, 2025 | 539,052.00 |
| Jun 30, 2025 | 352,177.00 |
| Mar 31, 2025 | 177,002.00 |
| Dec 31, 2024 | 15,709.00 |
| Sep 30, 2024 | 509,309.00 |
| Jun 30, 2024 | 430,309.00 |
| Mar 31, 2024 | 193,360.00 |
| Dec 31, 2023 | 2,760.00 |
| Sep 30, 2023 | 901.00 |
| Jun 30, 2023 | 811,176.00 |
| Mar 31, 2023 | 622,806.00 |
| Dec 31, 2022 | 427,933.00 |
| Sep 30, 2022 | 561,870.00 |
| Dec 31, 2021 | 142,721.00 |